161 related articles for article (PubMed ID: 26590370)
41. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer].
Liu HX; Xing LX; Wang HB; Yang JQ; Sun YM
Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):615-9. PubMed ID: 19094586
[TBL] [Abstract][Full Text] [Related]
42. EMAP-II expression is associated with macrophage accumulation in primary uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1801-6. PubMed ID: 12714608
[TBL] [Abstract][Full Text] [Related]
43. Differential expression of angioregulatory matricellular proteins in posterior uveal melanoma.
Ordonez JL; Paraoan L; Hiscott P; Gray D; García-Fiñana M; Grierson I; Damato B
Melanoma Res; 2005 Dec; 15(6):495-502. PubMed ID: 16314734
[TBL] [Abstract][Full Text] [Related]
44. Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas.
Barresi V; Cerasoli S; Tuccari G
Neuropathology; 2008 Oct; 28(5):472-8. PubMed ID: 18282163
[TBL] [Abstract][Full Text] [Related]
45. The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma.
Coupland SE; Anastassiou G; Stang A; Schilling H; Anagnostopoulos I; Bornfeld N; Stein H
J Pathol; 2000 Jun; 191(2):120-6. PubMed ID: 10861569
[TBL] [Abstract][Full Text] [Related]
46. Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey.
Ly LV; Odish OF; Wolff-Rouendaal Dd; Missotten GS; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):658-65. PubMed ID: 19797220
[TBL] [Abstract][Full Text] [Related]
47. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
48. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients.
Du ZM; Hu CF; Shao Q; Huang MY; Kou CW; Zhu XF; Zeng YX; Shao JY
Int J Cancer; 2009 Oct; 125(8):1832-41. PubMed ID: 19582878
[TBL] [Abstract][Full Text] [Related]
49. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL
Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022
[TBL] [Abstract][Full Text] [Related]
50. Cyclooxygenase-2 expression in human irradiated uveal melanomas.
Ozdal PC; Callejo S; Caissie AL; Edelstein C; Bakalian S; Vianna RN; Burnier MN
Int Ophthalmol; 2008 Feb; 28(1):1-6. PubMed ID: 17603773
[TBL] [Abstract][Full Text] [Related]
51. Melanoma inhibitory activity: a novel serum marker for uveal melanoma.
Schaller UC; Bosserhoff AK; Neubauer AS; Buettner R; Kampik A; Mueller AJ
Melanoma Res; 2002 Dec; 12(6):593-9. PubMed ID: 12459649
[TBL] [Abstract][Full Text] [Related]
52. Three-dimensional reconstruction of extravascular matrix patterns and blood vessels in human uveal melanoma tissue: techniques and preliminary findings.
Chen X; Ai Z; Rasmussen M; Bajcsy P; Auvil L; Welge M; Leach L; Vangveeravong S; Maniotis AJ; Folberg R
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2834-40. PubMed ID: 12824220
[TBL] [Abstract][Full Text] [Related]
53. Caveolin-1 tumor-promoting role in human melanoma.
Felicetti F; Parolini I; Bottero L; Fecchi K; Errico MC; Raggi C; Biffoni M; Spadaro F; Lisanti MP; Sargiacomo M; Carè A
Int J Cancer; 2009 Oct; 125(7):1514-22. PubMed ID: 19521982
[TBL] [Abstract][Full Text] [Related]
54. Cyclooxygenase-2 expression in uveal melanoma: novel classification of mixed-cell-type tumours.
Figueiredo A; Caissie AL; Callejo SA; McLean IW; Gold P; Burnier MN
Can J Ophthalmol; 2003 Aug; 38(5):352-6. PubMed ID: 12956275
[TBL] [Abstract][Full Text] [Related]
55. Vascular-Associated Muc4/Vwf Co-Localization in Human Conjunctival Malignant Melanoma Specimens-Tumor Metastasis by Migration?
Kakkassery V; Winterhalter S; Nick AC; Joachim SC; Joussen AM; Kociok N
Curr Eye Res; 2017 Oct; 42(10):1382-1388. PubMed ID: 28622066
[TBL] [Abstract][Full Text] [Related]
56. An evaluation of tumour vascularity as a prognostic indicator in uveal melanoma.
Lane AM; Egan KM; Yang J; Saornil MA; Alroy J; Albert D; Gragoudas ES
Melanoma Res; 1997 Jun; 7(3):237-42. PubMed ID: 9195563
[TBL] [Abstract][Full Text] [Related]
57. c-MET expression in primary and liver metastases in uveal melanoma.
Gardner FP; Serie DJ; Salomao DR; Wu KJ; Markovic SN; Pulido JS; Joseph RW
Melanoma Res; 2014 Dec; 24(6):617-20. PubMed ID: 25211165
[TBL] [Abstract][Full Text] [Related]
58. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.
Ayala G; Morello M; Frolov A; You S; Li R; Rosati F; Bartolucci G; Danza G; Adam RM; Thompson TC; Lisanti MP; Freeman MR; Vizio DD
J Pathol; 2013 Sep; 231(1):77-87. PubMed ID: 23729330
[TBL] [Abstract][Full Text] [Related]
59. The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma.
Meir T; Zeschnigk M; Masshöfer L; Pe'er J; Chowers I
Invest Ophthalmol Vis Sci; 2007 May; 48(5):1918-22. PubMed ID: 17460242
[TBL] [Abstract][Full Text] [Related]
60. Expression and clinical significance of pepsinogen C in uveal melanomas.
Alvarez ML; González LO; Barbón JJ; Astudillo A; Vizoso FJ
Int J Biol Markers; 2004; 19(3):240-4. PubMed ID: 15503827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
